tiprankstipranks
Anika Therapeutics (ANIK)
NASDAQ:ANIK
US Market
ANIK
Anika Therapeutics
RESEARCH TOOLSreports
Want to see ANIK full AI Analyst Report?

Anika Therapeutics (ANIK) Income Statement

178 Followers

Anika Therapeutics Income Statement

Last quarter (Q1 2026), Anika Therapeutics's total revenue was $29.61M, an increase of 13.16% from the same quarter last year. In Q1, Anika Therapeutics's net income was $-5.06M. See Anika Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 112.82M$ 119.91M$ 120.79M$ 113.83M$ 147.79M
Gross Profit
$ 63.81M$ 76.00M$ 82.53M$ 73.22M$ 82.94M
Operating Expenses
$ 74.86M$ 81.10M$ 81.69M$ 69.55M$ 80.33M
Depreciation and Amortization
$ 5.73M$ 8.12M$ 14.22M$ 14.49M$ 14.32M
EBITDA
$ -1.83M$ 3.02M$ 15.06M$ 18.16M$ -4.16M
Operating Income
$ -11.05M$ -5.10M$ 844.00K$ 3.67M$ 2.62M
Other Income/Expenses
$ 1.74M$ 2.34M$ 2.31M$ 654.00K$ -188.00K
Pretax Income
$ -9.31M$ -2.76M$ 3.16M$ 4.32M$ 2.43M
Net Income
$ -10.88M$ -56.38M$ -82.67M$ -14.86M$ 4.13M
Per Share Metrics
Basic EPS
$ -0.76$ -3.83$ -5.64$ -1.02$ 0.29
Diluted EPS
$ -0.76$ -3.83$ -5.64$ -1.02$ 0.28
Weighted Average Shares Outstanding
 14.34M 14.72M 14.66M 14.56M 14.40M
Weighted Average Shares Outstanding (Diluted)
 14.34M 14.72M 14.66M 14.56M 14.63M
Currency in USD

Anika Therapeutics Earnings and Revenue History